Simvastatin activates Keap1/Nrf2 signaling in rat liver

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Statins exhibit pleiotropic effects, including antioxidant activity.
• The Nrf2 transcription factor regulates cellular responses to oxidative stress.
• Understanding statin's antioxidant mechanisms is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the role of Nrf2 in mediating the antioxidant effects of statins.
• To elucidate the molecular pathways involved in statin-induced antioxidant responses.
• To determine if simvastatin's effects are cholesterol-dependent.

Main Methods:

• Utilized Wistar rats, primary hepatocytes, and ST2 cells for experimentation.
• Assessed Nrf2 nuclear translocation and DNA-binding activity in response to simvastatin.
• Measured the mRNA expression of Nrf2 target genes (HO-1, GPX2) and transcriptional activity.

Main Results:

• Simvastatin induced Nrf2 nuclear translocation in rat liver and hepatocytes via a mevalonate-dependent, cholesterol-independent pathway.
• Increased Nrf2 DNA-binding activity and induced HO-1 and GPX2 mRNA in simvastatin-treated rat liver.
• Simvastatin enhanced Nrf2-mediated transcriptional activity in ST2 cells, independent of cholesterol.

Conclusions:

• Simvastatin activates the Keap1/Nrf2 signaling pathway.
• This activation enhances cellular protection against oxidative stress.
• The findings suggest a novel mechanism for statin's antioxidant properties.